粥样硬化性-话题@MedSci - 梅斯（MedSci）

#粥样硬化性#

68篇内容 | 1977人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1804096, encodeId=1d0f1804096fc, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, objectType=article, longId=114840, objectId=e1501148404e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1501148404e, replyNumber=0, likeNumber=48, createdTime=2018-05-18, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1501148404e, moduleTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e1501148404e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804089, encodeId=71261804089c4, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, objectType=article, longId=95067, objectId=4e789506ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e789506ee8, replyNumber=0, likeNumber=65, createdTime=2017-07-31, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e789506ee8, moduleTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e789506ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804088, encodeId=de4318040880a, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理, objectType=article, longId=93438, objectId=5df19343852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df19343852, replyNumber=0, likeNumber=65, createdTime=2017-08-02, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df19343852, moduleTitle=Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5df19343852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804092, encodeId=ff7918040927f, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=阿司匹林在动脉粥样硬化性心血管疾病中的临床应用：中国专家共识（2016）, objectType=article, longId=107433, objectId=d12310e433ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12310e433ae, replyNumber=0, likeNumber=31, createdTime=2018-04-05, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12310e433ae, moduleTitle=阿司匹林在动脉粥样硬化性心血管疾病中的临床应用：中国专家共识（2016）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d12310e433ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804094, encodeId=2d4d18040943c, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=EUR HEART J ：低密度脂蛋白会引起动脉粥样硬化性心血管疾病！, objectType=article, longId=110565, objectId=366811056571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=366811056571, replyNumber=0, likeNumber=91, createdTime=2018-01-29, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=366811056571, moduleTitle=EUR HEART J ：低密度脂蛋白会引起动脉粥样硬化性心血管疾病！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=366811056571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804087, encodeId=e197180408ecf, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, objectType=article, longId=86894, objectId=d80d86894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d80d86894a4, replyNumber=0, likeNumber=34, createdTime=2017-11-03, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d80d86894a4, moduleTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d80d86894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804101, encodeId=3c2e180410161, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=J Am Coll Cardiol：多学科讨论：不吃早餐增加动脉粥样硬化性疾病风险, objectType=article, longId=118682, objectId=d2321186826f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2321186826f, replyNumber=0, likeNumber=66, createdTime=2018-01-15, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2321186826f, moduleTitle=J Am Coll Cardiol：多学科讨论：不吃早餐增加动脉粥样硬化性疾病风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d2321186826f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804093, encodeId=09c01804093b4, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=JAMA：动脉粥样硬化性心血管疾病患者降脂治疗的模拟研究, objectType=article, longId=108277, objectId=6a5d1082e74e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a5d1082e74e, replyNumber=0, likeNumber=64, createdTime=2017-12-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a5d1082e74e, moduleTitle=JAMA：动脉粥样硬化性心血管疾病患者降脂治疗的模拟研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a5d1082e74e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804098, encodeId=cf9b180409815, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Diabetes Care：当代2型糖尿病和动脉粥样硬化性患者的死亡原因分析！, objectType=article, longId=115865, objectId=7159115865c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7159115865c4, replyNumber=0, likeNumber=84, createdTime=2018-03-11, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7159115865c4, moduleTitle=Diabetes Care：当代2型糖尿病和动脉粥样硬化性患者的死亡原因分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7159115865c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804095, encodeId=2c16180409522, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=NEJM：动脉粥样硬化性疾病的抗炎治疗：卡那单抗, objectType=article, longId=111208, objectId=41af11120883, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41af11120883, replyNumber=0, likeNumber=94, createdTime=2018-02-06, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41af11120883, moduleTitle=NEJM：动脉粥样硬化性疾病的抗炎治疗：卡那单抗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=41af11120883)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804090, encodeId=9218180409030, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？, objectType=article, longId=98917, objectId=831b9891e07, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=831b9891e07, replyNumber=0, likeNumber=0, createdTime=2018-03-15, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=831b9891e07, moduleTitle=Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=831b9891e07)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804086, encodeId=b01b180408653, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, objectType=article, longId=81398, objectId=0d7181398c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7181398c2, replyNumber=0, likeNumber=71, createdTime=2017-02-19, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7181398c2, moduleTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d7181398c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804091, encodeId=ee16180409138, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识, objectType=article, longId=105315, objectId=f9041053153b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9041053153b, replyNumber=0, likeNumber=39, createdTime=2017-12-15, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9041053153b, moduleTitle=2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f9041053153b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804085, encodeId=6eb3180408519, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, objectType=article, longId=79680, objectId=0b07e9680d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b07e9680d3, replyNumber=0, likeNumber=53, createdTime=2017-01-06, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b07e9680d3, moduleTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b07e9680d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804080, encodeId=457218040809a, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, objectType=article, longId=68990, objectId=3d4a689900d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4a689900d, replyNumber=0, likeNumber=58, createdTime=2017-04-05, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4a689900d, moduleTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3d4a689900d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804082, encodeId=c6071804082ce, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加, objectType=article, longId=72000, objectId=8429e200075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8429e200075, replyNumber=0, likeNumber=61, createdTime=2016-12-17, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8429e200075, moduleTitle=Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8429e200075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804084, encodeId=03c418040844d, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, objectType=article, longId=74240, objectId=2639e42408c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2639e42408c, replyNumber=0, likeNumber=33, createdTime=2017-05-20, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2639e42408c, moduleTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2639e42408c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804077, encodeId=19fc18040e7af, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果, objectType=article, longId=61320, objectId=caab613201b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caab613201b, replyNumber=0, likeNumber=65, createdTime=2016-03-30, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caab613201b, moduleTitle=Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=caab613201b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804083, encodeId=a9df1804083b0, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, objectType=article, longId=72888, objectId=f5abe2888ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5abe2888ec, replyNumber=0, likeNumber=90, createdTime=2016-08-05, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5abe2888ec, moduleTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5abe2888ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804081, encodeId=0aaa180408124, content=<a href='/topic/show?id=d1b2e630123' target=_blank style='color:#2F92EE;'>#粥样硬化性#</a>, objectTitle=JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力, objectType=article, longId=69365, objectId=3c746936567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c746936567, replyNumber=0, likeNumber=59, createdTime=2016-12-09, rootId=0, userName=liubm555, userId=976a57, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c746936567, moduleTitle=JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3c746936567)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

粥样硬化性

2020-05-29

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果

2018-05-18

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布

2017-07-31

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理

2017-08-02

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

阿司匹林在动脉粥样硬化性心血管疾病中的临床应用：中国专家共识（2016）

2018-04-05

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

EUR HEART J ：低密度脂蛋白会引起动脉粥样硬化性心血管疾病！

2018-01-29

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）

2017-11-03

heli0118 (审核中...)

前往app查看评论内容

#粥样硬化性#

J Am Coll Cardiol：多学科讨论：不吃早餐增加动脉粥样硬化性疾病风险

2018-01-15

hb2008ye (审核中...)

前往app查看评论内容

#粥样硬化性#

JAMA：动脉粥样硬化性心血管疾病患者降脂治疗的模拟研究

2017-12-13

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Diabetes Care：当代2型糖尿病和动脉粥样硬化性患者的死亡原因分析！

2018-03-11

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

NEJM：动脉粥样硬化性疾病的抗炎治疗：卡那单抗

2018-02-06

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？

2018-03-15

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林

2017-02-19

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识

2017-12-15

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世

2017-01-06

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系

2017-04-05

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加

2016-12-17

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布

2017-05-20

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果

2016-03-30

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变

2016-08-05

liubm555 (审核中...)

前往app查看评论内容

#粥样硬化性#

JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力

2016-12-09

科室
- - 订阅+
  - 更多科室
工具
服务